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Abstract
Objective: The Metacognitions Questionnaire 30 assesses metacognitive beliefs and processes which are central to the
metacognitive model of emotional disorder. As recent studies have begun to explore the utility of this model for
understanding emotional distress after cancer diagnosis, it is important also to assess the validity of the Metacognitions
Questionnaire 30 for use in cancer populations.
Methods: 229 patients with primary breast or prostate cancer completed the Metacognitions Questionnaire 30 and the
Hospital Anxiety and Depression Scale pre-treatment and again 12 months later. The structure and validity of the
Metacognitions Questionnaire 30 were assessed using factor analyses and structural equation modelling.
Results: Confirmatory and exploratory factor analyses provided evidence supporting the validity of the previously published
5-factor structure of the Metacognitions Questionnaire 30. Specifically, both pre-treatment and 12 months later, this
solution provided the best fit to the data and all items loaded on their expected factors. Structural equation modelling
indicated that two dimensions of metacognition (positive and negative beliefs about worry) were significantly associated
with anxiety and depression as predicted, providing further evidence of validity.
Conclusions: These findings provide initial evidence that the Metacognitions Questionnaire 30 is a valid measure for use in
cancer populations.
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Introduction
Metacognition refers to the knowledge, beliefs and cognitive
processes involved in the monitoring, control and appraisal of
cognition [1,2]. The metacognitive model of psychological
disorder [2,3] states that emotional distress is maintained by
maladaptive and prolonged patterns of thinking (such as persistent
worry or rumination) which are activated and driven by
underlying metacognitive beliefs. Two types of metacognitive
belief are thought particularly important: positive beliefs about the
benefits of specific strategies for coping with distressing thoughts
and feelings (e.g. worrying will help me cope); and negative beliefs
about the danger and uncontrollability of perseverative thinking
(e.g. my worrying is uncontrollable). Positive beliefs about the
value of worrying and rumination are thought to activate use of
these strategies as a means of regulating emotion and cognition.
These strategies become pathological when negative metacogni-
tive beliefs are also activated so that worry or rumination itself
becomes the focus of negative appraisal – causing additional worry
about worry (meta-worry). In addition, negative beliefs about the
need to control thinking may lead to attempts to suppress
unwanted thoughts or worries, which typically has a paradoxical
effect, increasing their salience and intensifying emotional distress.
A second important component of metacognition for understand-
ing emotional distress is the cognitive processes that control and
monitor cognition. In particular, the metacognitive model suggests
that increased use of selective attention to, and monitoring of,
cognition leads to unwanted thoughts and feelings becoming more
salient [4]. A recent meta-analysis [5] concluded that Metacog-
nitive Therapy, which challenges metacognitive beliefs, is an
effective intervention for both anxiety and depressive disorders.
Such findings provide clear support for the value and importance
of the metacognitive model for understanding the maintenance of
emotional distress. The Metacognitions Questionnaire (MCQ) was
developed by Cartwright-Hatton and Wells [6] to explore the
metacognitive dimensions that are central in the metacognitive
model of emotional disorder. The initial 65-item, questionnaire
(MCQ-65) consisted of five subscales based on factor analyses,
three of which assess beliefs, including: ‘Positive beliefs about
worry’; ‘Negative beliefs about the danger and uncontrollability of
worry’; and ‘negative beliefs about thoughts in general’. The
remaining two subscales assess the tendency to focus on cognitive
events, ‘Cognitive self-consciousness’; and confidence in cognitive
abilities, particularly memory and attention, ‘Cognitive confi-
dence’. The MCQ-65 uses a four-point Likert response scale: 1 (do
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not agree); 2 (agree slightly); 3 (agree moderately); 4 (agree very
much).
However, despite excellent psychometric properties (see Wells
[1] for a review), the usefulness of the MCQ-65 was compromised
by its length; consequently a shorter 30-item version was
developed [7]. This MCQ-30 retained the factor structure and
the response scale of the longer measure, with six items selected to
represent each metacognitive dimension on the basis of highest
factor loading and item clarity in previous studies.
Initial psychometric properties of the MCQ-30 were found, in a
sample of 182 student and community participants, to be broadly
similar to those of the longer measure [7]. Internal consistency of
the subscales ranged from an adequate 0.72 to an excellent 0.93
with adequate test-retest reliability for four out of five subscales
(ranging from r= 0.59 ‘Negative beliefs about worry’ to r = 0.87
‘Cognitive self-consciousness’). Confirmatory and exploratory
factor analysis confirmed an acceptable fit of the original five
factor model with most items loading on their predicted factors
except in the case of ‘Need to control thoughts’ where only three
out of six items loaded significantly. In addition, all five subscales
were significantly and positively correlated with measures of worry
(Penn State Worry Questionnaire, PSWQ [8]) and Trait anxiety
(Stait - Trait Anxiety Inventory, STAI [9]) with the subscale
‘Negative beliefs about worry’ showing the strongest associations.
Further studies have since assessed the psychometric properties of
the MCQ-30 in mixed student and community samples in the UK
[10] and Turkey [11]. In both cases the original five factor
structure was replicated and positive correlations demonstrated
with theoretically appropriate measures of worry (PSWQ), anxiety
and depression.
Recently, interest has grown in applying the metacognitive
model to understanding emotional distress in cancer [12,13].
Thewes et al [13] used the MCQ-30 to explore for the first time
the association of metacognitive beliefs with Fear of Cancer
Recurrence (FCR) among young women with early stage breast
cancer. They found that the subscale ‘Negative beliefs about worry’
was the most highly correlated with FCR and that the MCQ-30
total score accounted for 36% of the variance in this outcome,
leading them to conclude that maladaptive metacognitions play an
important role in FCR. However, caution is warranted in the
interpretation of such findings because without formal psycho-
metric testing we do not yet know how the MCQ-30 operates in a
cancer population.
Consequently, the current study aims to explore for the first
time the validity of the MCQ-30 in cancer. The primary aim is
to explore whether the established 5-factor structure of the
MCQ-30 is valid in this population and to investigate the
internal consistency of its subscales. A second aim is to explore
whether the theoretically expected associations between specific
subscales of the MCQ-30 and anxiety and depression demon-
strated in previous research (Wells & Cartwright-Hatton, 2004;
Spada et al, 2008; Yilmaz et al, 2008) are replicated, thus
providing evidence of concurrent validity in this population. As
the association of metacognitive beliefs with emotional distress in
cancer had not been investigated before this study, this analysis
was exploratory with only one a priori hypothesis: that the
subscale ‘Negative beliefs about worry’ would be the main
predictor of variance in both anxiety and depression, as this
relationship has been consistently documented in mental health
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Participants
Participants were recruited from patients at least 18 years old
attending routine pre-treatment clinics at a National Health
Service (NHS) teaching hospital, after receiving a diagnosis of
primary non-metastatic breast or prostate cancer. Patients were
excluded if they had recurrent or metastatic disease, or were
considered by the clinical team or researcher to be too distressed
or confused to give informed consent.
Measures
The Metacognitions Questionnaire 30- (MCQ-30) [7] assesses
metacognitive beliefs and processes. It comprises five subscales:
‘Positive beliefs about worry’; ‘Negative beliefs about worry’;
‘Cognitive confidence’; ‘Need to control thoughts’; and ‘Cognitive
self-consciousness. For each subscale, six items are scored 1–4,
yielding total scores of 6 to 24. High scores indicate, respectively,
more positive and negative beliefs about worry, reduced
confidence in memory, greater belief in the need to control
thoughts and an increased tendency towards self-focussed atten-
tion. The MCQ-30 has excellent internal consistency and good
convergent and predictive validity in normal populations
[7,10,11].
The Hospital Anxiety and Depression scale (HADS) [15] was
used to assess anxiety and depression. The HADS is a well-
established measure of emotional distress specifically developed for
use in physically ill populations. Fourteen items are scored on a 4-
point scale yielding two subscale scores of 0-21 with high scores
indicating great anxiety or depression. The HADS has been
extensively validated for use in cancer [16,17] and is one of the
most widely employed measures of anxiety and depression
symptoms in this population.
Procedure
Data for this study was collected as part of a larger prospective
study exploring the association of metacognitive beliefs with
emotional distress after cancer [18]. Suitable participants were
identified by clinic staff, who gave them recruitment letters and
information sheets for the study along with their appointment
letters for routine pre-treatment consultations and explained that
participation in the research was entirely voluntary. When patients
attended the clinic, those willing to see the researcher were given
further information and asked for written consent. Participants
were asked to complete the study questionnaires in clinic and were
given the choice of electronic (hand-held PC) or paper formats.
Those unable to complete the questionnaires in clinic took a copies
(paper version) home and returned them by post. Twelve months
later participants were mailed a second questionnaire pack which
they completed and returned by post.
Data analysis
To explore the validity of the MCQ-30 over time and under
different circumstances, the data were analysed separately for both
time points (pre-treatment & 12 months later).
Construct validity of the MCQ-30 was first assessed using
Confirmatory Factor Analysis (CFA) to test the published five-
factor measurement model. As the primary aim of this study was to
assess validity rather than achieve the best possible model fit, the
Validation of the Metacognitions Questionnaire 30 (MCQ-30) in Cancer
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decision was taken not to make minor modifications to the model
based on the data (unless strongly supported by theory) as such
modifications often just reflect idiosyncratic characteristics of the
sample [19]. Instead, Exploratory Factor Analysis (EFA) was used
to explore whether an alternative model would be more
appropriate for this sample. Both sets of analyses (CFA and
EFA), were performed in Mplus version 6.12 [20], using the robust
weighted least squares estimator (WLSMV [21,22]) recommended
for ordinal categorical data [23]. The EFA tested models up to and
including a five-factor structure without dictating where items
should load. As previous studies identified MCQ-30 subscales as
inter-correlated, an oblique rotation (Geomin) was used to
establish the optimum pattern of item loadings. For both analyses
(CFA & EFA), adequacy of model fit was assessed based on two
incremental fit indices: the Comparative Fit Index (CFI); and the
Tucker-Lewis Fit Index (TLI), with values close to 0.95 indicating
a well-fitting model [24], and two absolute misfit indices: the Root
mean Square Error of Approximation (RMSEA) with values ,.05
indicating good fit and 0.5– .08 adequate fit [25]; and the
Weighted Root Mean Square Residual (WRMR) with values less
than .95 indicating good fit [26]. For the EFA the Standardised
Root mean Square (SRMR) was used, instead of the WRMR, with
values ,.05 indicating good fit. Inter-correlations amongst the five
latent factors of the published model were examined and the
internal consistency of each subscale assessed using Cronbach’s
alpha.
Concurrent validity of the MCQ-30 was then assessed (at each
time point) by fitting the data to a structural model in which latent
variables for anxiety and depression (each indicated by their seven
constituent HADS items), were regressed onto the MCQ-30
factors. Adequacy of model fit was again assessed using the fit
indices described above. As the MCQ-30 and HADS subscales
were not normally distributed and the study sample relatively
small, bootstrapping techniques were used to test the robustness of
the findings.
Results
Sample characteristics for the participants at each time point are
shown in Table 1.
Factorial Structure
Confirmatory factor analysis of the MCQ-30 five factor model
showed overall a marginally adequate fit of the model to the data
Table 1. Sample characteristics.
Pre-treatment 12 months follow-up
Total N 229 206
Age
Mean (SD) 61.3 (8.9) 61.5 (9.0)
Range 38–85 39–85
n (% of total N) n (% of total N)
Gender
Female 150 (66) 133
Male 79 (34) 73
Marital status
Married/co-habiting 151 (66) 139
Live alone 46 (20%) 37
Education
None 88 (38) 76
School qualifications or higher 132 (58) 121
Employment
Employed (full/part-time) 88 (38) 79
Retired 99 (43) 92
Retired (health) 16 (7) 14
Homemaker 13 (6) 9
Unemployed 10 (4) 9
Cancer diagnosis
Breast 150 (66) 133
Prostate 79 (34) 73
Tumour grade
Low 56 (24) 54
Intermediate 107 (47) 97
High 62 (27) 52
N.B. Missing data T1 (T2): Marital Status n = 5(5); Live alone n = 3(2); Education n = 9 (9); Employment n = 3(3); Tumour grade n = 4(3).
doi:10.1371/journal.pone.0107302.t001
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at the pre-treatment assessment: x2 (395) = 787.448. p,. 01,
RMSEA = .066 (90% CI= .059–.073), CFI = .91, TLI = .90,
WRMR =1.218.
Exploratory Factor analysis which, unlike CFA, does not dictate
where items should load, confirmed that a five-factor solution
nevertheless provided the best model. Moreover, the fit indices (x2
(295) = 439.692. P,.001, RMSEA = .046 (90% CI= .037–.055),
CFI = .97, TLI = .95, SRMR =0.046) together indicate a good
fit of the model to this data. As shown in Table 2, all items loaded
.0.4 on their expected factors [7]. However, as the items were
allowed to load freely across any factors, minor discrepancies were
observed between the EFA–derived solution and the published five
factor model. Specifically, two items, MCQ3 and MCQ13, had
their highest loadings on factors other than the expected ones.
Item MCQ3 loaded higher on ‘Negative beliefs about worry’ (F1)
than on its expected factor - ‘Cognitive self-consciousness’ (F4).
Item MCQ13 had equivalent loadings on both its expected factors
- ‘Need for control over thoughts’ (F5) - and ‘Cognitive self-
Table 2. Published scale structure and rotated (Geomin) factor loadings from EFA of the Metacognitions Questionnaire-30 at pre-
treatment.
MCQ-30 PUBLISHED SCALE STRUCTURE & ITEMS EFA FACTOR LOADINGS
F1 F2 F3 F4 F5
Subscale: Positive beliefs about worry
MCQ-1 Worrying helps me to avoid problems in the future 0.08 0.66 0.15 20.19 0.05
MCQ-7 I need to worry in order to remain organized 0.09 0.85 20.17 20.03 0.05
MCQ-10 Worrying helps me to get things sorted out in my mind 0.05 0.88 20.05 0.10 20.14
MCQ-19 Worrying helps me cope 20.04 0.85 0.03 0.12 0.03
MCQ-23 Worrying helps me to solve problems 20.10 0.85 0.05 0.09 0.04
MCQ-28 I need to worry in order to work well 20.04 0.79 0.05 0.10 0.18
Subscale: Negative beliefs about worry
MCQ-2 My worrying is dangerous for me 0.58 20.17 20.02 0.10 0.14
MCQ-4 I could make myself sick with worrying 0.65 20.01 0.01 0.11 20.03
MCQ-9 My worrying thoughts persist, no matter how I try to stop them 0.70 0.27 0.04 20.07 20.03
MCQ-11 I cannot ignore my worrying thoughts 0.69 0.39 20.02 0,01 20.12
MCQ-15 My worrying could make me go mad 0.62 20.14 0.28 0.20 0.18
MCQ-21 When I start worrying, I cannot stop 0.76 0.19 0.08 20.07 0.09
Subscale: Cognitive confidence
MCQ-8 I have little confidence in my memory for words and names 0.04 0.07 0.81 20.06 20.03
MCQ-14 My memory can mislead me at times 0.19 20.03 0.60 0.24 20.07
MCQ-17 I have a poor memory 0.05 0.02 0.88 20.03 20.05
MCQ-24 I have little confidence in my memory for places 20.10 0.05 0.82 0.04 0.10
MCQ-26 I do not trust my memory 20.07 20.03 0.77 20.03 0.30
MCQ-29 I have little confidence in my memory for actions 0.04 0.06 0.57 20.09 0.47
Subscale: Need for control over thoughts
MCQ-6 If I did not control a worrying thought, and then it happened, it would be my
fault.
0.39 0.17 20.14 20.10 0.52
MCQ-13 I should be in control of my thoughts all of the time 20.04 20.11 20.01 0.41 0.41
MCQ-20 Not being able to control my thoughts is a sign of weakness 0.32 0.06 20.06 0.03 0.64
MCQ-22 I will be punished for not controlling certain thoughts 0.15 0.15 0.21 0.07 0.72
MCQ-25 It is bad to thinks certain thoughts 0.13 20.02 0.11 0.18 0.50
MCQ-27 If I could not control my thoughts, I would not be able to function 20.07 20.00 20.05 0.27 0.64
Subscale: Cognitive self-consciousness
MCQ-3 I think a lot about my thoughts 0.56 0.01 20.01 0.43 20.06
MCQ-5 I am aware of the way my mind works when I am thinking through a
problem
0.14 0.17 20.07 0.49 20.42
MCQ-12 I monitor my thoughts 20.03 0.08 20.12 0.66 0.02
MCQ-16 I am constantly aware of my thinking 0.27 0.02 0.05 0.66 0.05
MCQ-18 I pay close attention to the way my mind works 20.02 0.08 0.03 0.83 0.02
MCQ-30 I constantly examine my thoughts 0.31 0.05 0.01 0.55 0.27
N.B. F1 ‘Negative beliefs about worry’ F2 ‘Positive beliefs about worry’ F3 ‘Cognitive confidence’ F4 ‘Need for control over thoughts’ F5 ‘Cognitive Self-conciousness’;
Bold = loading ..4; Underline = highest loading where item loads ..4 on more than one factor.
doi:10.1371/journal.pone.0107302.t002
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consciousness’ (F4). Two further items (MCQ5 & MCQ29) also
demonstrated significant (..4) cross-loadings although for both the
highest loading remained consistent with the published factor
structure.
At the 12 month follow-up, CFA indicated an adequate fit of the
data to the published five-factor model: x2 (395) = 684.184. p,.
01, RMSEA = .060 (90% CI= .053–.068, (p RMSEA,.05,
.015), CFI = .95, TLI = .95, WRMR =1.048. Therefore no
Exploratory Factor Analysis was performed.
The Mean and SDs of the five MCQ-30 subscales and the
correlations amongst the five latent variables (CFA standardised
solution) at both time points are presented in Table 3. The
internal consistency of the subscales was assessed using Cronbach’s
alpha (Table 3) and ranged from 0.73 to 0.89 pre-treatment and
from .79 to .91 at 12 month follow-up, indicating adequate to
excellent internal consistency. At both time points the subscale
with the lowest alpha coefficient was ‘Need for Control’.
Convergent validity
The hypothesised model of the relationship between metacog-
nitive beliefs (using the MCQ-30’s published factor structure) and
concurrent anxiety and depression is shown in Figure 1. Overall,
the fit indices for this latent variable SEM (see Table 4) indicated
an acceptable fit of the model. At both time points, ‘Negative
beliefs about worry’ explained significant variance in both anxiety
and depression and, as hypothesised, was the strongest of all the
predictors. ‘Positive beliefs about worry’ also explained variance in
anxiety at both time points but not depression. At the pre-
treatment time-point ‘Need for control over thoughts’ was
associated with fewer symptoms of anxiety, although this
association fell just short of significant (p = .057) at the twelve-
month follow-up. There was no significant relationship between
‘Cognitive confidence’ or ‘Cognitive self-consciousness’ and anxiety
or depression at either time-point.
Discussion
The present study provides the first evidence to support the
published five-factor structure of the MCQ-30 [7] as valid and
replicable in a cancer population. Although at the pre-treatment
time point CFA showed only a marginal fit, subsequent EFA
confirmed that a five-factor solution still provided the best solution.
The improved fit observed for the EFA over the CFA was the
result of items being allowed to load freely across any of the
factors. However, all items still loaded on their expected factors
with only minor discrepancies between the two models. At 12-
month follow-up, fit was acceptable and comparable to that
reported by the measure’s developers [7]. It is not clear why the fit
should be slightly better at the 12 month follow-up. The mode of
administration differed between the two time points with pre-
treatment assessments largely being carried out on hand-held PCs
while 12 month follow-up were completed on paper. Improved fit
at follow-up might therefore arise because the procedure for this
assessment is closer to how the questionnaires have been
administered during previous validation studies. Equally, the
observed improvement in fit could be partly due to the timing of
assessments in that the pre-treatment assessment was conducted
relatively soon after diagnosis, during a period that is clinically
busy and often emotionally turbulent. In contrast, the twelve
month follow-up for most is likely to be a more settled time, at least
clinically. However, taken together, these CFA and EFA results
suggest that the established five factor structure of the MCQ-30 is
valid for use in a cancer population and that it remains valid across
one year post-diagnosis and changing illness/treatment circum-
stances. In addition, the results indicate that the subscales possess
good internal consistency comparable to those found in previous
studies [7,10,11].
Two items (MCQ3 & MCQ13) had their highest loadings on a
different factor to that expected. However, only one of these
loaded higher on that factor; Item MCQ3 (‘I think a lot about my
thoughts’) had its highest loading on ‘Positive beliefs about worry’
rather than the expected factor ‘Cognitive self-consciousness’. Both
of these items have also been found to cross-load on different
Table 3. Descriptive data, internal consistency and inter-correlations among the five latent MCQ-30 factors (CFA standardised
solution).
Pre-treatment
Mean (SD) Median (IQR) POS NEG CC NC CSC Alpha
POS 9.2 (3.95) 8 (8.7–9.7) 1 .57** .29** .59** .55** .89
NEG 11.2 (4.17) 11 (10.6–11.7) 1 .42** .58** .64** .80
CC 10.0 (4.10) 9 (9.5–10.6) 1 .46** .18* .85
NC 10.1 (3.68) 9.0 (9.6–10.6) 1 .64** .73
CSC 13.3 (4.39) 13 (12.7–13.9) 1 .79
12 month follow-up
Mean (SD) Median (IQR) POS NEG CC NC CSC Alpha
POS 9.02 (3.97) 7.0(6–11) 1 .71** .45** .68** .62** .91
NEG 10.8 (4.48) 10.0 (7–14) 1 .68** .65** .73** .85
CC 11.21 (5.01) 10.0 (7–14) 1 .43** .37* .91
NC 9.82 (3.89) 9.0 (7–11) 1 .72** .79
CSC 12.41 (4.63) 12.0 (8.9–16) 1 .85
N.B. MCQ-30 subscales: ‘Positive beliefs about worry’ (POS); ‘Negative beliefs about worry’ (NEG); ‘Cognitive Confidence’ (CC); ‘Need for control over thoughts’ (NC);
‘Cognitive Self Consciousness’ (CSC) *p,.05; **p,.001.
doi:10.1371/journal.pone.0107302.t003
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factors previously [11] although, in that study, item MCQ3 loaded
.0.4 on ‘Negative beliefs about worry’ not on ‘Positive beliefs
about worry’ as in the present study.
Preliminary evidence of the measure’s convergent validity is
provided by the structural equation model of the relationship of
the MCQ-30 latent factors with anxiety and depression. As
hypothesised, and as shown previously in mental health, physical
health, student and community populations, ‘Negative beliefs
about worry’ was the strongest predictor of both anxiety
([7,10,11,14] and depression [10,11]. In addition, ‘Positive beliefs
about worry’ predicted anxiety at both time points. However, in
contrast, ‘Need for control over thoughts’ was negatively related to
Figure 1. Structural equation model of the relationship between the MCQ-30 and HADS anxiety and HADS depression. N.B.
Rectangles indicate observed variables on MCQ-30 (MCQ) or HADS (H); ellipses indicate latent factors. Latent factors: Positive beliefs about worry (POS);
Negative beliefs about worry (NEG); Cognitive Confidence (CC); Need to control thoughts (NC); Cognitive Self-consciousness (CSC); HADS Anxiety (HADS-
A); HADS Depression (HADS-D). Figures show standardised path coefficients and their significance at pre-treatment and (in brackets) 12-month
follow-up. Errors not shown; *** p,.001 ** p,.01 * p,.05
doi:10.1371/journal.pone.0107302.g001
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anxiety at pre-treatment although this relationship was marginally
non-significant at twelve month follow-up. This suggest that
participants with lower conviction about the need to control their
thinking experience greater anxiety. Such findings are unexpected
as previous studies in mental health, student and community
samples have indicated that greater belief in the need to control
thoughts, predict higher rather than lower levels of anxiety. This
result may indicate a difference between this and previously
studied mental health, student and community populations.
However, further work would be required to establish whether
this is a true population difference or just an artefact of the present
data.
It is important to note that, by structural equation modelling
standards, the study employed a small sample size, which may
reduce the stability of the findings. Consequently, further work is
required to establish whether the apparent differential item
functioning and observed patterns of associations represent real
population differences or are idiosyncratic to this data set. In
addition, as only breast and prostate cancer patients were included
in the study, it remains important to explore whether study
findings can be replicated across different cancer diagnoses.
In summary, the current study provides initial evidence that the
established five-factor structure of the MCQ-30 is valid for use in a
cancer population and that the subscales possess good internal
consistency. Positive and negative beliefs about worry were
associated with concurrent anxiety and depression as expected,
although the negative relationship of anxiety with ‘Need for control
over thoughts’ is unexpected and therefore intriguing. Despite the
limitations discussed above we conclude from this study that, the
MCQ-30 is a sufficiently valid measure for assessing metacognitive
beliefs and processes in breast or prostate cancer populations in
the first year after diagnosis.
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